Drug class
Bisphosphonate ligand; diagnostic radiopharmaceutical precursor for technetium-99m skeletal imaging
Mechanism of action
Medronic acid (methylene diphosphonate, MDP) chelates technetium-99m after reconstitution of a radiopharmaceutical kit. The labelled complex has affinity for hydroxyapatite in bone and accumulates in proportion to regional blood flow and osteoblastic activity, allowing skeletal scintigraphy.
General use cases
- Used as the active ligand in technetium Tc-99m medronate (Tc-99m MDP) kits for skeletal scintigraphy and imaging of areas of increased osteogenic activity. The diagnostic imaging agent is the technetium-labelled product, not unlabelled medronic acid alone.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
